Published in J Pharm Biomed Anal on November 18, 2008
Determination of lamivudine and stavudine in pharmaceutical preparations using chemometrics-assisted spectrophotometry. Saudi Pharm J (2009) 0.86
Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates. Biomed Chromatogr (2014) 0.78
Metabolism of proline and the hydroxyprolines. Annu Rev Biochem (1980) 2.91
Mapping quantitative trait loci for murine growth: a closer look at genetic architecture. Genet Res (1999) 2.27
High pressure versus low pressure electromagnetic extracorporeal lithotripsy. J Urol (1993) 2.03
Erythromycin is a motilin receptor agonist. Am J Physiol (1989) 2.00
Breakdown of self-tolerance in anergic B lymphocytes. Nature (1991) 1.87
Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev (1996) 1.77
Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol (1996) 1.65
Reproduction of radiologic images on plain paper. Radiographics (1998) 1.65
Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int (1978) 1.63
Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol (1989) 1.56
Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol (2000) 1.55
Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab (2001) 1.52
Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer (1975) 1.48
The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev (2001) 1.40
Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer (2000) 1.33
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Isolation and structural characterization of polymyxin B components. J Chromatogr A (2001) 1.31
Coenzyme content of purified alanine racemase from Pseudomonas. Biochem Biophys Res Commun (1969) 1.30
Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol (1998) 1.26
Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice. Antimicrob Agents Chemother (1998) 1.26
Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25
Isolation and structural characterization of colistin components. J Antibiot (Tokyo) (2001) 1.23
Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res (1970) 1.23
Self tolerance in the B-cell repertoire. Immunol Rev (1991) 1.22
Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci (2000) 1.21
Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J Pharm Biomed Anal (2004) 1.19
D-lysine catabolic pathway in Pseudomonas putida: interrelations with L-lysine catabolism. J Bacteriol (1974) 1.19
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
The impact of illness and the impact of school closure on social contact patterns. Health Technol Assess (2010) 1.15
Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol (1997) 1.15
Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables. J Antimicrob Chemother (2001) 1.14
Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol (1997) 1.14
Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol (1998) 1.13
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol (1998) 1.13
Renal pseudotumor due to a retained perirenal sponge: CT features. J Comput Assist Tomogr (1992) 1.12
Antimalarial activity of Ajuga remota Benth (Labiatae) and Caesalpinia volkensii Harms (Caesalpiniaceae): in vitro confirmation of ethnopharmacological use. J Ethnopharmacol (2001) 1.10
Synthesis and antiviral activity of acyclic nucleosides with a 3(S),5-dihydroxypentyl or 4(R)-methoxy-3(S),5-dihydroxypentyl side chain. J Med Chem (1992) 1.10
Invertebrate collagens. Science (1978) 1.07
Fluorometric determination of pyridoxal phosphate in enzymes. Methods Enzymol (1979) 1.07
Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm (2002) 1.07
Inducible degradation of hydroxyproline in Pseudomonas putida: pathway regulation and hydroxyproline uptake. J Bacteriol (1969) 1.06
Conservative management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2006) 1.06
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Clin Exp Immunol (1997) 1.05
T cell receptor-triggered activation of intraepithelial lymphocytes in vitro. Int Immunol (1993) 1.04
Chemo-denitrification of nitrate-polluted water. Environ Pollut (1990) 1.04
Investigation of vancomycin and related substances by liquid chromatography/ion trap mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.01
Expression of murine IL-12 is regulated by translational control of the p35 subunit. J Immunol (1999) 1.00
Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer (1976) 1.00
Quantitative determination by high-performance liquid chromatography of acetylsalicylic acid and related substances in tablets. J Chromatogr (1987) 1.00
Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release (2005) 0.99
Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostatic carcinoma. J Urol (1994) 0.99
Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol (1998) 0.99
Partial reaction of prolyl hydroxylase. (Gly-PRO-Ala)n stimulates alpha-ketoglutarate decarboxylation without prolyl hydroxylation. J Biol Chem (1978) 0.98
Group interpersonal psychotherapy for postnatal depression: a pilot study. Arch Womens Ment Health (2005) 0.98
Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm (2007) 0.98
Total synthesis of bisnorpenicillin V. J Med Chem (1974) 0.97
Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gynecol Oncol (1989) 0.97
Nelson's syndrome. Eur J Endocrinol (2010) 0.97
Liquid chromatography of polymyxin B sulphate. J Chromatogr A (2000) 0.97
Alpha-ketoglutaric semialdehyde dehydrogenase of Pseudomonas. Properties of the purified enzyme induced by hydroxyproline and of the glucarate-induced and constitutive enzymes. J Biol Chem (1967) 0.97
Exophytic papillary prostatic duct adenocarcinoma with endometrioid features, occurring in prostatic urethra after TURP. Urology (1994) 0.96
Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int J Pharm (2002) 0.96
Secondary pyelo-pyelic anastomosis in renal transplant patients. Urology (1990) 0.96
Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder. J Urol (1992) 0.96
Over-expression of a gibberellin 2-oxidase gene from Phaseolus coccineus L. enhances gibberellin inactivation and induces dwarfism in Solanum species. Plant Cell Rep (2007) 0.95
Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95
The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem Pharmacol (1996) 0.95
Itraconazole formulation studies of the melt-extrusion process with mixture design. Drug Dev Ind Pharm (2003) 0.95
Controlled release of chlorhexidine from amorphous microporous silica. J Control Release (2009) 0.95
PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release (2012) 0.94
Simulated intestinal fluid as transport medium in the Caco-2 cell culture model. Int J Pharm (2002) 0.94
Catalytic aspects of enzymatic racemization. Adv Enzymol Relat Areas Mol Biol (1976) 0.94
Long-term toxicity study of mycophenolic acid in rabbits. Toxicol Appl Pharmacol (1975) 0.94
Fluorometric determination of pyridoxal phosphate in enzymes. Anal Biochem (1969) 0.93
Kinetic and structural studies of hydroxyproline 2-epimerase. J Biol Chem (1970) 0.93
Non-contact ultra-widefield imaging of retinopathy of prematurity using the Optos dual wavelength scanning laser ophthalmoscope. Eye (Lond) (2013) 0.93
Sequence position of 3-hydroxyproline in basement membrane collagen. Isolation of glycyl-3-hydroxyprolyl-4-hydroxyproline from swine kidney. J Biol Chem (1975) 0.92
Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial. Lancet (2000) 0.91
Influence of polyethylene glycol/polyethylene oxide on the release characteristics of sustained-release ethylcellulose mini-matrices produced by hot-melt extrusion: in vitro and in vivo evaluations. Eur J Pharm Biopharm (2009) 0.91
Using experimental design to optimize the process parameters in fluidized bed granulation. Drug Dev Ind Pharm (2001) 0.91
Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91
Supplementary water for breast-fed babies in a hot and dry climate--not really a necessity. Arch Dis Child (1983) 0.91
Glutarate semialdehyde dehydrogenase of Pseudomonas. Purification, properties, and relation to L-lysine catabolism. J Biol Chem (1977) 0.90
Antibody-dependent cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis. Lancet (1976) 0.90
Calcific constructive pericarditis: a rare complication of CREST syndrome. Arthritis Rheum (1996) 0.90
Improved reversed-phase liquid chromatographic method combined with pulsed electrochemical detection for the analysis of amikacin. J Pharm Biomed Anal (2006) 0.90
Studies in gram staining. Stain Technol (1975) 0.90
Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg (1999) 0.89
Study of the stability of polymyxins B(1), E(1) and E(2) in aqueous solution using liquid chromatography and mass spectrometry. J Pharm Biomed Anal (2002) 0.89
Is the diverticulum of the distal and collecting tubules a preliminary stage of the simple cyst in the adult? J Urol (1977) 0.89
Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosomes Cancer (1994) 0.89
Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol (1998) 0.89